Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes

Identifying patients who do not respond to standard therapy

Sean P. Collins, Christopher J. Lindsell, Alan B. Storrow, Gregory J. Fermann, Phillip D. Levy, Peter Pang, Neal Weintraub, W. Frank Peacock, Douglas B. Sawyer, Mihai Gheorghiade

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Clinical trials for acute heart failure syndromes (AHFS) have traditionally enrolled patients well after emergency department (ED) presentation. We hypothesized a large proportion of patients would undergo changes in clinical profiles during the first 24 h of hospitalization, and these changes would be associated with adverse events. We evaluated a prospective cohort of patients with clinical data available at ED presentation and 12-24 h after ED treatment for AHFS. Patients were categorized into distinct clinical profiles at these time points based on (1) systolic blood pressure: a-hypertensive ([160 mmHg); b-normotensive (100-159 mmHg); or c-hypotensive (\100 mmHg); (2) moderate-to-severe renal dysfunction (GFR B 60 ml/min/ 1.73 m2); and (3) presence of troponin positivity. A composite outcome of 30-day cardiovascular events was determined by phone follow-up. In the 370 patients still hospitalized with data available at the 12-24 h time point, 196 (53.0%) had changed their clinical profiles, with 117 (59.7%) improving and 79 (40.3%) worsening. The composite 30-day event rate was 16.9%. Patients whose clinical profile started and stayed abnormal had a significantly greater proportion of events than those who started and stayed normal (26.1% vs. 11.3%; P = 0.03). Patients with abnormal clinical profiles at presentation that remain abnormal throughout the first 12-24 h of hospitalization are at increased risk of 30-day adverse events. Future clinical trials may need to consider targeting these patients, as they may be the most likely to benefit from experimental therapy.

Original languageEnglish (US)
Pages (from-to)387-394
Number of pages8
JournalHeart Failure Reviews
Volume17
Issue number3
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Emergency Treatment
Hospital Emergency Service
Heart Failure
Therapeutics
Hospitalization
Clinical Trials
Blood Pressure
Investigational Therapies
Troponin
Kidney

Keywords

  • Clinical trials
  • Early enrollment
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes : Identifying patients who do not respond to standard therapy. / Collins, Sean P.; Lindsell, Christopher J.; Storrow, Alan B.; Fermann, Gregory J.; Levy, Phillip D.; Pang, Peter; Weintraub, Neal; Peacock, W. Frank; Sawyer, Douglas B.; Gheorghiade, Mihai.

In: Heart Failure Reviews, Vol. 17, No. 3, 05.2012, p. 387-394.

Research output: Contribution to journalArticle

Collins, Sean P. ; Lindsell, Christopher J. ; Storrow, Alan B. ; Fermann, Gregory J. ; Levy, Phillip D. ; Pang, Peter ; Weintraub, Neal ; Peacock, W. Frank ; Sawyer, Douglas B. ; Gheorghiade, Mihai. / Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes : Identifying patients who do not respond to standard therapy. In: Heart Failure Reviews. 2012 ; Vol. 17, No. 3. pp. 387-394.
@article{35f6a64fd97444f7a48248cc3923e721,
title = "Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: Identifying patients who do not respond to standard therapy",
abstract = "Clinical trials for acute heart failure syndromes (AHFS) have traditionally enrolled patients well after emergency department (ED) presentation. We hypothesized a large proportion of patients would undergo changes in clinical profiles during the first 24 h of hospitalization, and these changes would be associated with adverse events. We evaluated a prospective cohort of patients with clinical data available at ED presentation and 12-24 h after ED treatment for AHFS. Patients were categorized into distinct clinical profiles at these time points based on (1) systolic blood pressure: a-hypertensive ([160 mmHg); b-normotensive (100-159 mmHg); or c-hypotensive (\100 mmHg); (2) moderate-to-severe renal dysfunction (GFR B 60 ml/min/ 1.73 m2); and (3) presence of troponin positivity. A composite outcome of 30-day cardiovascular events was determined by phone follow-up. In the 370 patients still hospitalized with data available at the 12-24 h time point, 196 (53.0{\%}) had changed their clinical profiles, with 117 (59.7{\%}) improving and 79 (40.3{\%}) worsening. The composite 30-day event rate was 16.9{\%}. Patients whose clinical profile started and stayed abnormal had a significantly greater proportion of events than those who started and stayed normal (26.1{\%} vs. 11.3{\%}; P = 0.03). Patients with abnormal clinical profiles at presentation that remain abnormal throughout the first 12-24 h of hospitalization are at increased risk of 30-day adverse events. Future clinical trials may need to consider targeting these patients, as they may be the most likely to benefit from experimental therapy.",
keywords = "Clinical trials, Early enrollment, Heart failure",
author = "Collins, {Sean P.} and Lindsell, {Christopher J.} and Storrow, {Alan B.} and Fermann, {Gregory J.} and Levy, {Phillip D.} and Peter Pang and Neal Weintraub and Peacock, {W. Frank} and Sawyer, {Douglas B.} and Mihai Gheorghiade",
year = "2012",
month = "5",
doi = "10.1007/s10741-011-9294-7",
language = "English (US)",
volume = "17",
pages = "387--394",
journal = "Heart Failure Reviews",
issn = "1382-4147",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes

T2 - Identifying patients who do not respond to standard therapy

AU - Collins, Sean P.

AU - Lindsell, Christopher J.

AU - Storrow, Alan B.

AU - Fermann, Gregory J.

AU - Levy, Phillip D.

AU - Pang, Peter

AU - Weintraub, Neal

AU - Peacock, W. Frank

AU - Sawyer, Douglas B.

AU - Gheorghiade, Mihai

PY - 2012/5

Y1 - 2012/5

N2 - Clinical trials for acute heart failure syndromes (AHFS) have traditionally enrolled patients well after emergency department (ED) presentation. We hypothesized a large proportion of patients would undergo changes in clinical profiles during the first 24 h of hospitalization, and these changes would be associated with adverse events. We evaluated a prospective cohort of patients with clinical data available at ED presentation and 12-24 h after ED treatment for AHFS. Patients were categorized into distinct clinical profiles at these time points based on (1) systolic blood pressure: a-hypertensive ([160 mmHg); b-normotensive (100-159 mmHg); or c-hypotensive (\100 mmHg); (2) moderate-to-severe renal dysfunction (GFR B 60 ml/min/ 1.73 m2); and (3) presence of troponin positivity. A composite outcome of 30-day cardiovascular events was determined by phone follow-up. In the 370 patients still hospitalized with data available at the 12-24 h time point, 196 (53.0%) had changed their clinical profiles, with 117 (59.7%) improving and 79 (40.3%) worsening. The composite 30-day event rate was 16.9%. Patients whose clinical profile started and stayed abnormal had a significantly greater proportion of events than those who started and stayed normal (26.1% vs. 11.3%; P = 0.03). Patients with abnormal clinical profiles at presentation that remain abnormal throughout the first 12-24 h of hospitalization are at increased risk of 30-day adverse events. Future clinical trials may need to consider targeting these patients, as they may be the most likely to benefit from experimental therapy.

AB - Clinical trials for acute heart failure syndromes (AHFS) have traditionally enrolled patients well after emergency department (ED) presentation. We hypothesized a large proportion of patients would undergo changes in clinical profiles during the first 24 h of hospitalization, and these changes would be associated with adverse events. We evaluated a prospective cohort of patients with clinical data available at ED presentation and 12-24 h after ED treatment for AHFS. Patients were categorized into distinct clinical profiles at these time points based on (1) systolic blood pressure: a-hypertensive ([160 mmHg); b-normotensive (100-159 mmHg); or c-hypotensive (\100 mmHg); (2) moderate-to-severe renal dysfunction (GFR B 60 ml/min/ 1.73 m2); and (3) presence of troponin positivity. A composite outcome of 30-day cardiovascular events was determined by phone follow-up. In the 370 patients still hospitalized with data available at the 12-24 h time point, 196 (53.0%) had changed their clinical profiles, with 117 (59.7%) improving and 79 (40.3%) worsening. The composite 30-day event rate was 16.9%. Patients whose clinical profile started and stayed abnormal had a significantly greater proportion of events than those who started and stayed normal (26.1% vs. 11.3%; P = 0.03). Patients with abnormal clinical profiles at presentation that remain abnormal throughout the first 12-24 h of hospitalization are at increased risk of 30-day adverse events. Future clinical trials may need to consider targeting these patients, as they may be the most likely to benefit from experimental therapy.

KW - Clinical trials

KW - Early enrollment

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84862574142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862574142&partnerID=8YFLogxK

U2 - 10.1007/s10741-011-9294-7

DO - 10.1007/s10741-011-9294-7

M3 - Article

VL - 17

SP - 387

EP - 394

JO - Heart Failure Reviews

JF - Heart Failure Reviews

SN - 1382-4147

IS - 3

ER -